Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

232.75
-1.8100-0.77%
Post-market: 233.050.3000+0.13%17:39 EDT
Volume:796.45K
Turnover:185.00M
Market Cap:30.13B
PE:-106.81
High:237.77
Open:230.36
Low:228.28
Close:234.56
Loading ...
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]